Logo image of JKS

JINKOSOLAR HOLDING CO-ADR (JKS) Stock Fundamental Analysis

NYSE:JKS - New York Stock Exchange, Inc. - US47759T1007 - ADR - Currency: USD

24.29  -0.12 (-0.49%)

After market: 24.25 -0.04 (-0.16%)

Fundamental Rating

3

Taking everything into account, JKS scores 3 out of 10 in our fundamental rating. JKS was compared to 110 industry peers in the Semiconductors & Semiconductor Equipment industry. JKS may be in some trouble as it scores bad on both profitability and health. JKS has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

JKS had positive earnings in the past year.
Each year in the past 5 years JKS has been profitable.
Of the past 5 years JKS 4 years had a positive operating cash flow.
JKS Yearly Net Income VS EBIT VS OCF VS FCFJKS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B

1.2 Ratios

With a Return On Assets value of -1.53%, JKS is not doing good in the industry: 60.91% of the companies in the same industry are doing better.
JKS has a worse Return On Equity (-10.18%) than 68.18% of its industry peers.
Industry RankSector Rank
ROA -1.53%
ROE -10.18%
ROIC N/A
ROA(3y)1.06%
ROA(5y)0.92%
ROE(3y)7.15%
ROE(5y)6.05%
ROIC(3y)N/A
ROIC(5y)N/A
JKS Yearly ROA, ROE, ROICJKS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

In the last couple of years the Profit Margin of JKS has declined.
The Gross Margin of JKS (8.39%) is worse than 90.91% of its industry peers.
JKS's Gross Margin has declined in the last couple of years.
JKS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-67.68%
PM growth 5Y-54.4%
GM growth 3Y-12.56%
GM growth 5Y-9.8%
JKS Yearly Profit, Operating, Gross MarginsJKS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

2

2. Health

2.1 Basic Checks

JKS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for JKS has been reduced compared to 1 year ago.
Compared to 5 years ago, JKS has more shares outstanding
The debt/assets ratio for JKS has been reduced compared to a year ago.
JKS Yearly Shares OutstandingJKS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
JKS Yearly Total Debt VS Total AssetsJKS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

A Debt/Equity ratio of 2.37 is on the high side and indicates that JKS has dependencies on debt financing.
With a Debt to Equity ratio value of 2.37, JKS is not doing good in the industry: 94.55% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.37
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC1.47%
JKS Yearly LT Debt VS Equity VS FCFJKS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B 30B

2.3 Liquidity

A Current Ratio of 1.33 indicates that JKS should not have too much problems paying its short term obligations.
With a Current ratio value of 1.33, JKS is not doing good in the industry: 85.45% of the companies in the same industry are doing better.
A Quick Ratio of 1.07 indicates that JKS should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.07, JKS is not doing good in the industry: 85.45% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 1.07
JKS Yearly Current Assets VS Current LiabilitesJKS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

5

3. Growth

3.1 Past

The earnings per share for JKS have decreased strongly by -74.20% in the last year.
The Earnings Per Share has been decreasing by -2.87% on average over the past years.
The Revenue for JKS has decreased by -29.85% in the past year. This is quite bad
JKS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 25.40% yearly.
EPS 1Y (TTM)-74.2%
EPS 3Y13.84%
EPS 5Y-2.87%
EPS Q2Q%-334.93%
Revenue 1Y (TTM)-29.85%
Revenue growth 3Y31.23%
Revenue growth 5Y25.4%
Sales Q2Q%333.76%

3.2 Future

The Earnings Per Share is expected to grow by 39.23% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 5.82% on average over the next years.
EPS Next Y-305.48%
EPS Next 2Y-21.26%
EPS Next 3Y39.23%
EPS Next 5YN/A
Revenue Next Year-23.45%
Revenue Next 2Y-0.03%
Revenue Next 3Y5.82%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
JKS Yearly Revenue VS EstimatesJKS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B 80B 100B
JKS Yearly EPS VS EstimatesJKS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 -5 10

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 9.10 indicates a reasonable valuation of JKS.
98.18% of the companies in the same industry are more expensive than JKS, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of JKS to the average of the S&P500 Index (27.41), we can say JKS is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 14.67, the valuation of JKS can be described as correct.
Based on the Price/Forward Earnings ratio, JKS is valued cheaply inside the industry as 87.27% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 35.19. JKS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 9.1
Fwd PE 14.67
JKS Price Earnings VS Forward Price EarningsJKS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, JKS is valued a bit cheaper than 72.73% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 18.14
JKS Per share dataJKS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

JKS's earnings are expected to grow with 39.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-21.26%
EPS Next 3Y39.23%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 11.33%, JKS is a good candidate for dividend investing.
JKS's Dividend Yield is rather good when compared to the industry average which is at 2.17. JKS pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.35, JKS pays a better dividend.
Industry RankSector Rank
Dividend Yield 11.33%

5.2 History

JKS has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
JKS Yearly Dividends per shareJKS Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.5 1

5.3 Sustainability

DPN/A
EPS Next 2Y-21.26%
EPS Next 3Y39.23%
JKS Yearly Income VS Free CF VS DividendJKS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B

JINKOSOLAR HOLDING CO-ADR

NYSE:JKS (7/14/2025, 4:13:13 PM)

After market: 24.25 -0.04 (-0.16%)

24.29

-0.12 (-0.49%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)04-29 2025-04-29/bmo
Earnings (Next)08-28 2025-08-28/bmo
Inst Owners31.67%
Inst Owner Change0%
Ins Owners4.9%
Ins Owner ChangeN/A
Market Cap1.25B
Analysts48.57
Price Target24.47 (0.74%)
Short Float %56.57%
Short Ratio6.39
Dividend
Industry RankSector Rank
Dividend Yield 11.33%
Yearly Dividend1.47
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years1
Ex-Date07-02 2025-07-02 (1.3)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-43.84%
Min Revenue beat(2)-87.91%
Max Revenue beat(2)0.23%
Revenue beat(4)1
Avg Revenue beat(4)-65.23%
Min Revenue beat(4)-88.32%
Max Revenue beat(4)0.23%
Revenue beat(8)1
Avg Revenue beat(8)-75.42%
Revenue beat(12)4
Avg Revenue beat(12)-47.58%
Revenue beat(16)5
Avg Revenue beat(16)-37.16%
PT rev (1m)0%
PT rev (3m)-7.18%
EPS NQ rev (1m)14.7%
EPS NQ rev (3m)-53.63%
EPS NY rev (1m)9.24%
EPS NY rev (3m)-451.11%
Revenue NQ rev (1m)0.24%
Revenue NQ rev (3m)1.88%
Revenue NY rev (1m)-1.54%
Revenue NY rev (3m)-9.67%
Valuation
Industry RankSector Rank
PE 9.1
Fwd PE 14.67
P/S 0.11
P/FCF N/A
P/OCF N/A
P/B 0.49
P/tB 0.56
EV/EBITDA 18.14
EPS(TTM)2.67
EY10.99%
EPS(NY)1.66
Fwd EY6.82%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS224.33
BVpS49.71
TBVpS43.52
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.53%
ROE -10.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.39%
FCFM N/A
ROA(3y)1.06%
ROA(5y)0.92%
ROE(3y)7.15%
ROE(5y)6.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-67.68%
PM growth 5Y-54.4%
GM growth 3Y-12.56%
GM growth 5Y-9.8%
F-ScoreN/A
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 2.37
Debt/FCF N/A
Debt/EBITDA 14.22
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.33
Quick Ratio 1.07
Altman-Z N/A
F-ScoreN/A
WACC1.47%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-74.2%
EPS 3Y13.84%
EPS 5Y-2.87%
EPS Q2Q%-334.93%
EPS Next Y-305.48%
EPS Next 2Y-21.26%
EPS Next 3Y39.23%
EPS Next 5YN/A
Revenue 1Y (TTM)-29.85%
Revenue growth 3Y31.23%
Revenue growth 5Y25.4%
Sales Q2Q%333.76%
Revenue Next Year-23.45%
Revenue Next 2Y-0.03%
Revenue Next 3Y5.82%
Revenue Next 5YN/A
EBIT growth 1Y-189.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year430.72%
EBIT Next 3Y131.27%
EBIT Next 5YN/A
FCF growth 1Y-45.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.87%
OCF growth 3Y239.49%
OCF growth 5Y64.22%